P53 and cyclin D1 staining patterns of malignant and premalignant oral lesions in age-dependent populations.
OBJECTIVE
Recent epidemiologic studies have identified a trend of increasing cancer incidence in younger patients. The purpose of this study was to determine whether this might be reflected by different molecular mechanisms for tumor development.


METHODS
Dysplastic and malignant oral lesions from age-distinct patient populations were immunohistochemically analyzed for expression of p53 and cyclin D1. Chi-square analysis was used to determine statistical significance.


RESULTS
Eighty-two percent of "older" and 75% of "younger" carcinomas stained positively with p53; 63% of carcinomas in the older population and 55% of carcinomas in the younger population showed cyclin D1 positivity. Dysplasias showed similar cyclin D1 staining in both groups. Interestingly, 100% of "younger" dysplasias stained positively for p53, whereas 35.3% of "older" dysplastic lesions showed immunoreactivity. Staining of carcinomas was not statistically significant, whereas p53 staining of dysplasias proved highly significant (P < .025).


CONCLUSIONS
p53 immunoreactivity is detectable at an earlier stage of carcinogenesis in younger patients than in the traditional risk population for oral cancer.
Castle
J T
JT
Department of Oral Pathology, National Naval Dental Center, Bethesda, MD, USA. castle@afip.osd.mil
Cardinali
M
M
Kratochvil
F J
FJ
Abbondanzo
S L
SL
Kessler
H P
HP
Auclair
P L
PL
Yeudall
W A
WA
D000328:Adult; D000367:Age Factors; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D016009:Chi-Square Distribution; D019938:Cyclin D1 / Q000032:analysis / Q000378:metabolism*; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D009363:Neoplasm Proteins / Q000032:analysis; D011230:Precancerous Conditions / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D016159:Tumor Suppressor Protein p53 / Q000032:analysis / Q000378:metabolism*
D009363:Neoplasm Proteins; D016159:Tumor Suppressor Protein p53; D019938:Cyclin D1